Woolums Amelia R, Ensley Douglas T, Tanner Patrick A, Fankhauser Rebecca, Shen Jing, Songer J Glenn, Leard A Timothy, Milward Francis W, Pence Mel E, Hurley David J
Departments of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.
Am J Vet Res. 2011 Aug;72(8):1124-9. doi: 10.2460/ajvr.72.8.1124.
To evaluate injection-site reactions and serum antibody titers in cattle vaccinated with a clostridial vaccine administered SC or via needle-free transdermal injection.
Sixteen 11-to 12-month-old Herefords.
Cattle in 2 groups were vaccinated on days 0 and 28 with a commercially available multivalent clostridial vaccine administered SC or transdermally Injection sites and serum antibody titers were evaluated at several time points after vaccination. Serum antibody titers against Clostridium perfringens beta toxin, Clostridium novyi alpha toxin, and Clostridium septicum alpha toxin were determined with an ELISA; Clostridium sordellii lethal toxin titers were determined with a toxin neutralization assay.
Firm injection site swellings developed in cattle vaccinated via either route; however, at several observation times, swellings were significantly smaller in cattle vaccinated transdermally. Serum titers against C perfringens beta toxin and C septicum alpha toxin did not differ significantly between groups after vaccination; serum titers against C novyi alpha toxin were not significantly different between groups, except on days 10 and 56, when they were significantly higher in cattle vaccinated SC. Titers against C sordellii lethal toxin were significantly higher in cattle vaccinated SC on several days after vaccination, but titers were not significantly different after day 49.
Transdermal vaccination of cattle resulted in serum antibody titers that were similar to those induced via SC vaccination and caused injection-site reactions that were significantly smaller. Transdermal vaccination may be an effective technique for vaccinating cattle against clostridial diseases while minimizing local reactions that often develop after clostridial vaccination.
评估经皮下(SC)注射或无针透皮注射给予梭菌疫苗的牛的注射部位反应和血清抗体滴度。
16头11至12月龄的赫里福德牛。
两组牛分别于第0天和第28天通过皮下注射或透皮给予市售多价梭菌疫苗进行接种。在接种后的几个时间点评估注射部位和血清抗体滴度。用酶联免疫吸附测定法(ELISA)测定针对产气荚膜梭菌β毒素、诺维氏梭菌α毒素和败血梭菌α毒素的血清抗体滴度;用毒素中和试验测定索氏梭菌致死毒素滴度。
两种接种途径的牛均出现注射部位硬结肿胀;然而,在几个观察时间点,经透皮接种的牛的肿胀明显较小。接种后两组之间针对产气荚膜梭菌β毒素和败血梭菌α毒素的血清滴度无显著差异;针对诺维氏梭菌α毒素的血清滴度在两组之间无显著差异,但在第10天和第56天时,皮下接种的牛的血清滴度显著更高。接种后几天内,皮下接种的牛针对索氏梭菌致死毒素的滴度显著更高,但在第49天后滴度无显著差异。
牛的透皮接种所产生的血清抗体滴度与皮下接种诱导产生的滴度相似,且引起的注射部位反应明显较小。透皮接种可能是一种有效的技术,可用于给牛接种梭菌病疫苗,同时将梭菌疫苗接种后常出现的局部反应降至最低。